TOXLINK
LIVE

Serial Number

79266897

Owner

Abbott Toxicology Limited

Attorney

Michele H. Bowman

Filing Date

Apr 4, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TOXLINK Trademark

Serial Number: 79266897 • Registration: 6279457

TOXLINK is a trademark filed by Abbott Toxicology Limited on April 4, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Abbott Toxicology Limited (2 trademarks)

21 Blacklands Way

Entity Type: 99

Alere Toxicology Plc

21 Blacklands Way,

Entity Type: 99

Trademark Details

Filing Date

April 4, 2019

Registration Date

March 2, 2021

Published for Opposition

December 15, 2020

Goods & Services

Downloadable software for administering, scanning, interpreting, and reporting and information in the fields of toxicology, forensics, drug testing, and alcohol testing; downloadable mobile applications for administering, scanning, interpreting, and reporting data and information in the fields of toxicology, forensics, drug testing, and alcohol testing; downloadable software and downloadable mobile applications for administering, scanning, and interpreting results of rapid drug screening devices; downloadable software and downloadable mobile applications for administering, scanning, and interpreting results of rapid alcohol screening devices; drug testing cups for laboratory use for the detection of drugs in blood or other bodily fluids, not for medical purposes; alcohol testing cups for laboratory use for the detection of alcohol in blood or other bodily fluids, not for medical purposes; laboratory devices for analyzing blood and other bodily fluids, for drug and alcohol screening and testing, not for medical purposes; laboratory devices for rapid drug screening testing, not for medical purposes, for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine; forensic drug and alcohol testing kits comprising non-medical laboratory devices for analyzing blood and other bodily fluids, not for medical purposes; forensic kits comprising non-medical laboratory devices for testing for the presence of analytes in biological fluids, other fluids and other matrices, not for medical purposes; kits comprising non-medical laboratory devices for collecting and testing biological fluid for the presence of drugs and drug metabolites, not for medical purposes; kits comprising non-medical laboratory devices for collecting and testing biological fluid for the presence of alcohol and metabolites, not for medical purposes

Medical apparatus and instruments for the screening of drugs and alcohol, namely, medical diagnostic devices for analyzing blood and other bodily fluids for the presence of drugs and alcohol; medical diagnostic and immunodiagnostic apparatus and instruments for the screening of drugs and alcohol, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; drug and alcohol testing analyzers for medical purposes, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; drug and alcohol testing cups, namely, testing cups featuring rapid lateral flow chromatographic immunoassays for drug and alcohol screening purposes, for medical purposes; drug and alcohol testing instruments for medical purposes, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; drug and alcohol testing systems comprising medical apparatus and instruments for medical purposes, for analyzing blood and other bodily fluids for the presence of drugs and alcohol; medical drug testing kits comprising medical apparatus and instruments, for analyzing blood and other bodily fluids for the presence of drugs; medical alcohol testing kits comprising medical apparatus and instruments, for analyzing blood and other bodily fluids for the presence of alcohol; kits comprising medical apparatus and instruments for testing for the presence of analytes in biological fluids, other fluids and other matrices, all for medical purposes; kits comprising medical apparatus and instruments for collecting and testing biological fluid for the presence of drugs and drug metabolites, for medical use; kits comprising medical apparatus and instruments for collecting and testing biological fluid for the presence of alcohol and alcohol metabolites, for medical use; drug testing cups for use in drug screening of urine; alcohol testing cups for use in alcohol screening of urine; drug screening testing apparatus for medical use, for analyzing blood and other bodily fluids for the presence of drugs; alcohol screening testing apparatus for medical use, for analyzing blood and other bodily fluids for the presence of alcohol; rapid drug screening testing apparatus for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine, for medical purposes

Diagnostic reagents and chemical reagents, not for medical purposes; immunodiagnostic reagents, not for medical purposes; buffer solutions, not for medical purposes; immunoassay chemical test strips, not for medical purposes; drug testing kits comprising diagnostic and chemical reagents and assays, not for medical purposes; alcohol testing kits comprising diagnostic and chemical reagents and assays, not for medical purposes; drug testing kits comprised of diagnostic reagents and assays for testing body fluids, not for medical purposes; kits comprising diagnostic and chemical reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, not for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, not for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of alcohol and alcohol metabolites, not for medical purposes; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine, not for medical purposes

Diagnostic reagents and chemical reagents, for medical purposes; medical diagnostic and immunodiagnostic reagents, for medical purposes; drug and alcohol testing kits comprising diagnostic and chemical reagents and assays, for medical purposes; drug and alcohol testing kits comprised of diagnostic reagents and assays for testing body fluids, for medical purposes; kits comprising diagnostic and chemical reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, for medical purposes; kits comprising diagnostic and chemical reagents and assays for collecting and testing oral fluid for the presence of alcohol and alcohol metabolites, for medical purposes; rapid drug screening tests comprised of diagnostic and chemical reagents for the simultaneous, qualitative detection of multiple drugs and/or metabolites in human urine, for medical purposes

Software as a service (SAAS) services featuring online non-downloadable scientific software for use in database management and reporting in the fields of toxicology, forensics, drug testing, and alcohol testing; server hosting services for others featuring online databases for the provision of information in the fields of toxicology, forensics, drug testing, drug screening, alcohol screening, and alcohol testing; hosting online non-downloadable data management and reporting portals, namely, hosting websites for others in the fields of toxicology, forensics, drug testing, drug screening, alcohol testing, and alcohol screening; laboratory toxicology services; hosting online non-downloadable data management and reporting portals, namely, providing online non-downloadable software for others in the fields of toxicology, forensics, drug testing, drug screening, alcohol testing, and alcohol screening; laboratory toxicology services; laboratory toxicology services; laboratory drug testing services for forensic research purposes; design and development of computer software for use with medical and non-medical technology

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 2, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 3, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 5, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 27, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 3, 2021 FICS
FINAL DISPOSITION PROCESSED
Jun 3, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 2, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 6, 2021 OPNX
REGISTERED-PRINCIPAL REGISTER
Mar 2, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 17, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 17, 2021 OPNR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2021 ADCH
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 15, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 15, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 25, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 6, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 6, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 6, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 6, 2020 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
May 7, 2020 GNFN
FINAL REFUSAL E-MAILED
May 7, 2020 GNFR
FINAL REFUSAL WRITTEN
May 7, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2020 CRFA
ASSIGNED TO LIE
Apr 10, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 3, 2020 TROA
REFUSAL PROCESSED BY IB
Oct 26, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 5, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 5, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 27, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 26, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 17, 2019 MAFR
ASSIGNED TO EXAMINER
Sep 13, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 13, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 12, 2019 REPR